These findings establish a closed-loop regulatory axis of “UBE2V1–VHL–HIF-1α” and reveal a novel regulatory mechanism by which HCC tumor cells adapt to the hypoxic microenvironment, offering experimental support for targeting UBE2V1 in the treatment of HCC. The gene discussed is HIF1A; the disease is neoplasm.